Traders should watch for potential downward pressure on the stock, especially if this selling reflects broader concerns among leadership. A 1%+ insider sell-off by directors is significant and often precedes negative news or weak performance. Monitor upcoming earnings, clinical trial updates, or further disclosures for catalysts.
SION drugs
SION drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 15 $45.09entry
- T+1 · 7mo ago +0.33%α +0.08% · $45.24
- T+5 · 7mo ago −4.19%α −5.83% · $43.20
- T+20 · 6mo ago −9.20%α −15.25% · $40.94
- T+60 · 4mo ago +0.44%α −7.69% · $45.29
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two directors, ORBIMED ADVISORS LLC and Thompson Peter A., each sold approximately 235,900 shares of Sionna Therapeutics in open-market transactions on April 15, 2026, at $44.64 per share, totaling $10.53 million each, for a combined $21.06 million in insider sales over a 7-day window. This represents a material cluster of selling by key insiders, amounting to 1.05% of the company's $2.0B market cap. The coordinated timing and size suggest strategic divestment rather than routine portfolio management.
Key Financial Metrics
Key Facts
- Two insiders, both directors, sold a combined $21.06 million in shares over 7 days.
- All transactions were open-market sales (S) at prices between $44.51 and $45.34.
- Total cluster value equals 1.05% of Sionna Therapeutics' $2.0B market capitalization.
- Thompson Peter A. and ORBIMED ADVISORS LLC each sold ~235.9K shares on the same day (2026-04-15), indicating coordination.
Financial Impact
$21.06 million in insider selling over 7 days
Risk Factors
- Perception of insider confidence loss, especially given the size and coordination.
- Potential for follow-on selling if other shareholders interpret this as a signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SION-1776381339614 |
Track record
22 reports on SION
6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +89.29% at T+60 after the Jul 9, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 10, 20266d ago Press Release Neutral 5/10 Entry $3.70 Now $3.12 −15.68% settles Nov 17
- Nov 9, 20267d ago SC 13G Neutral 3/10 Entry $3.57 to $3.12 Now $3.12 −12.61% ▼ −12.61% −10.91% vs SPY
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $3.65 to $3.70 Now $3.12 −14.52% ▲ +1.37% +1.96% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $6.02 to $5.15 Now $3.12 −48.17% ▼ −14.45% −13.26% vs SPY
- Sep 21, 20268w ago SC 13D/A Bearish 7/10 Entry $6.02 to $5.15 Now $3.12 +48.17% ▲ +14.45% +13.26% vs SPY
- Sep 17, 20268w ago 144 Bearish 5/10 Entry $5.96 to $5.23 Now $3.12 +47.65% ▲ +12.25% +13.52% vs SPY
- Aug 10, 202614w ago 8-K Bearish 7/10 Entry $4.50 to $5.91 Now $3.12 +30.67% ▼ −31.33% −31.38% vs SPY
- Aug 6, 202614w ago 8-K Neutral 4/10 Entry $49.61 to $6.54 Now $3.12 −93.71% ▼ −86.82% −88.03% vs SPY
- Jul 9, 202618w ago Insider Cluster Neutral 4/10 Entry $45.29 to $45.29 Now $3.12 −93.11% · 0.00% +0.56% vs SPY
- Jul 9, 202618w ago Insider Cluster Bearish 5/10 Entry $45.29 to $45.29 Now $3.12 +93.11% · 0.00% −0.56% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers